{"disease":{"id":"b-cell-mediated-autoimmune-disorders","name":"b cell mediated autoimmune disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06680037","title":"A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"TG Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07148791","title":"Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}